Global Topical Corticosteroids Market, By Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High, Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others) – Industry Trends and Forecast to 2030.
Topical Corticosteroids Market Analysis and Size
According to the World Health Organization (WHO), over 339 million people worldwide suffered from asthma, making it a common condition among children. Furthermore, nearly 251 million people worldwide suffered from COPD in 2016. COPD is anticipated to increase in the future coupled with the considerable prevalence of smoking and ageing populations in several countries. The rising prevalence of asthma and COPD has increased the demand for inhaled corticosteroids for disease management. These are anti-inflammatory medications that are commonly used as an effective long-term asthma control medication. It helps to reduce swelling and tightness in the airways.
Data Bridge Market Research analyses that the topical corticosteroids market which is USD 3996.91 million in 2022, is expected to reach USD 6418.71 million by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Topical Corticosteroids Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Molecule Name (Fludroxycortide, Triamcinolone Acetonide, Fluocinolone Acetonide, Antiseptics, Betamethasone, Clobetasone Propionate, Clobetasone Butyrate, Halobetasone, Mometasone, Others), Potency Class (Ultra-High, High, Moderate, Low), Medication Type (Ointments, Creams, Liquid and Solutions, Lotions, Gel, Oils, Pastes, Sprays, Others), Application (Acne, Dermatitis, Psoriasis, Skin Infection, Hyperpigmentation, Melasma, Others), Distribution Channel (Hospital Pharmacies, Pharmacy Stores, Online Pharmacies, Others), End User (Hospital, Dermatology Clinics, Homecare, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Gsk plc (U.K.), Almirall, S.A (Spain), Merck & Co., Inc. (Germany), Bausch Health (Canada), Sandoz International GmbH (Germany), Pfizer Inc. (U.S.), AstraZeneca (U.K.), Sanofi (France), Bayer AG (Germany), McKesson Corporation (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Medtronic (Ireland), AbbVie Inc. (U.S.), GALDERMA LABORATORIES, L.P. (U.S.), Novartis AG (Switzerland), LEO Pharma A/S (Denmark), Cipla Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.) and Mylan N.V. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Corticosteroids are steroid hormones that are produced either naturally or artificially. The adrenal cortex produces these hormones. Topical corticosteroids, hydrocortisone-derived compounds with distinct anti-inflammatory potency, are widely used to treat a wide range of inflammatory diseases. Patients are given synthetic corticosteroids when their bodies or adrenal cortex fail to produce the necessary corticosteroids.
Topical Corticosteroids Market Dynamics
Drivers
- Research and Development Activities
The increasing number of research and development activities related to topical corticosteroids by market players is expected to aid in the growth of the topical corticosteroids (steroids) market over the forecast period. For instance, in April 2022, Eli Lilly and Company, a global healthcare company, announced that Lebrikizumab, an IL-13 inhibitor, significantly improved disease severity when combined with topical corticosteroids (TCS) in people with moderate-to-severe atopic dermatitis (AD) in third pivotal Phase 3 trial (ADhere).
- Rising prevalence of skin-related diseases
The rising prevalence of skin-related diseases, such as rashes, dermatitis, itching, eczema, and psoriasis, aided in the growth of the corticosteroid market. According to the Centers for Disease Control, at least 2 million people in the United States are infected with antibiotic-resistant bacteria each year, and at least 23,000 people die as a result of such infections. According to a 2019 European Academy of Dermatology and Venereology report, of the 2,701 people polled, 1,662 (64.5%) had at least one skin disorder. The most common diagnoses were rosacea (25.5%), eczema (11.7%), and actinic keratosis (26.6%). Skin disorders increased with age and were more prevalent in men (72.3%) than in women (58.0%). The rising prevalence of such disorders increased the demand for corticosteroids, driving the market.
Opportunities
- Increasing number of cases of eczema and atopic dermatitis
The rising prevalence of eczema and atopic dermatitis is expected to drive the global topical corticosteroids (steroids) market. According to the Allergy & Asthma Network, approximately 31.6 million people in the United States had eczema in 2020, with 15% of children and 7.3% of adults suffering from atopic dermatitis.
Restraints/Challenges
- High costs associated with R&D capabilities
High costs associated with R&D capabilities, limited infrastructural facilities, uneven distribution of medical services, and a lack of awareness in backward economies are expected to hamper the market growth. In addition, a lack of favourable reimbursement scenario and technology penetration in developing economies, a decline in healthcare expenses in advancing countries, rising patent expiry, government pricing pressure, side effects of topical corticosteroids, and a lack of suitable infrastructure in low- and middle-income countries are expected to challenge the market during the forecast period of 2023-2030.
This topical corticosteroids market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the topical corticosteroids market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Topical Corticosteroids Market
COVID-19 had a positive impact on the market. They can be very effective in treating COVID patients because topical corticosteroids are widely used in the pharmaceutical industry. The rising rate of hospitalisation due to the increasing prevalence of coronavirus infection has fueled the market growth rate even further. In addition, the increasing use of topical corticosteroids in nasal sprays and medications such as hydrocortisone accelerated the rate of growth. Furthermore, with the increased relaxation following the pandemic, the market is expected to grow by leaps and bounds.
Recent Developments
- In 2022, Lilly's lebrikizumab and topical corticosteroids demonstrated significant improvements in atopic dermatitis disease severity.
- In 2022, the first patient in a pilot study evaluating vamorolone as a potential treatment for Becker muscular dystrophy was dosed (BMD). The steroid medication has been under development by ReveraGen BioPharma as a possible therapy for other types of muscular dystrophy.
Global Topical Corticosteroids Market Scope
The topical corticosteroids market is segmented on the basis of molecule name, potency class, medication type, application, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Molecule name
- Fludroxycortide
- Triamcinolone Acetonide
- Fluocinolone Acetonide
- Antiseptics
- Betamethasone
- Clobetasone Propionate
- Clobetasone Butyrate
- Halobetasone
- Mometasone
- Others
Potency class
- Ultra-High
- Clobetasol propionate
- Diflorasone diacetate
- High
- Amcinonide
- Betamethasone dipropionate
- Desoximetasone
- Fluocinonide
- Halcinonide
- Others
- Moderate
- Desoximetasone
- Fluocinolone Acetonide
- Fludroxycortide
- Hydrocortisone Valerate
- Triamcinolone Acetonide
- Others
- Low
- Betamethasone Valerate
- Desonide
- Fluocinolone Acetonide
- Others
Medication type
- Ointments
- Creams
- Liquid and Solutions
- Lotions
- Gel
- Oils
- Pastes
- Sprays
- Others
Application
- Acne
- Dermatitis
- Psoriasis
- Skin Infection
- Hyperpigmentation
- Melasma
- Others
Distribution channel
- Hospital Pharmacies
- Pharmacy Stores
- Online Pharmacies
- Others
End user
- Hospital
- Dermatology Clinics
- Homecare
- Others
Topical Corticosteroids Market Regional Analysis/Insights
The topical corticosteroids market is analyzed and market size insights and trends are provided by country, molecule name, potency class, medication type, application, distribution channel and end user as referenced above.
The countries covered in the topical corticosteroids market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the topical corticosteroids market because of the region's well-developed healthcare infrastructure and favourable reimbursement policies.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing incidence of cancer such as bladder, esophagus, liver, pancreas, and others, high presence of major manufacturers across the U.S. Furthermore, technological advancements and rising foreign investment.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Topical Corticosteroids Market Share Analysis
The topical corticosteroids market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to topical corticosteroids market.
Some of the major players operating in the topical corticosteroids market are:
- Gsk plc (U.K.)
- Almirall, S.A (Spain)
- Merck & Co., Inc. (Germany)
- Bausch Health (Canada)
- Sandoz International GmbH (Germany)
- Pfizer Inc. (U.S.)
- AstraZeneca (U.K.)
- Sanofi (France)
- Bayer AG (Germany)
- McKesson Corporation (U.S.)
- Regeneron Pharmaceuticals Inc. (U.S.)
- Medtronic (Ireland)
- AbbVie Inc. (U.S.)
- GALDERMA LABORATORIES, L.P. (U.S.)
- Novartis AG (Switzerland)
- LEO Pharma A/S (Denmark)
- Cipla Inc. (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Mylan N.V. (U.S.)
SKU-